<DOC>
	<DOCNO>NCT00708708</DOCNO>
	<brief_summary>This prospective observational cohort study assess average duration drug free interval etanercept treatment cycle usual care setting Germany .</brief_summary>
	<brief_title>Observational Study Evaluating Etanercept ( EnbrelÂ® ) In Subjects With Plaque-Type Psoriasis In Usual Care Settings</brief_title>
	<detailed_description>Non-interventional study : subject select accord usual clinical practice physician</detailed_description>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Subjects moderate severe plaque psoriasis etanercept treatment accord Summary Product Characteristics ( SmPC ) , applicable local guideline Subjects decision already make initiate treatment etanercept Sepsis risk sepsis Current recent infection , include chronic localize , e.g . tuberculosis ( TB ) infection Vaccination live vaccine last 4 week , expect require vaccination course study Preexisting recent onset CNS demyelinate disease . Class III IV congestive heart failure define New York Heart Association classification uncompensated congestive heart failure . Previous ongoing treatment etanercept Participation clinical observational study . Patients psoriatic arthritis require continuous etanercept treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Plaque-type psoriasis</keyword>
</DOC>